NARATRIPTAN (NARATRIPTAN HYDROCHLORIDE) — FDA Approval ANDA202431 (AUROBINDO PHARMA USA)
NARATRIPTAN (NARATRIPTAN HYDROCHLORIDE) — FDA Approval ANDA202431 (AUROBINDO PHARMA USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NARATRIPTAN; Active ingredients: NARATRIPTAN HYDROCHLORIDE; Application number: ANDA202431.
| Brand name | NARATRIPTAN |
|---|---|
| Active ingredients | NARATRIPTAN HYDROCHLORIDE |
| Application number | ANDA202431 |
| Sponsor | AUROBINDO PHARMA USA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20120531 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →